Literature DB >> 15862931

Disturbances of motility and visceral hypersensitivity in irritable bowel syndrome: biological markers or epiphenomenon.

Eamonn M M Quigley1.   

Abstract

Motility and visceral hypersentitivity are regarded as the primary mechanisms of symptom development in irritable bowel syndrome(IBS). While a variety of motor abnormalities have been described throughout the gastrointestinal tract in IBS, their specificity and relationship to symptoms remain unclear. Visceral hypersensitivity is ubiquitous in functional gastrointestinal disease and is especially common in IBS. Again, however, its specificity for IBS has been questioned. Many factors, including stress and psychopathology,complicate the interpretation of these phenomena and new re-search suggests that mucosal inflammation and luminal factors may be more fundamental to the etiology of this common disorder.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15862931     DOI: 10.1016/j.gtc.2005.02.010

Source DB:  PubMed          Journal:  Gastroenterol Clin North Am        ISSN: 0889-8553            Impact factor:   3.806


  8 in total

1.  Bad language in gastroenterology.

Authors:  Fergus Shanahan; Eamonn M M Quigley
Journal:  Curr Gastroenterol Rep       Date:  2008-04

Review 2.  Irritable bowel syndrome: a microbiome-gut-brain axis disorder?

Authors:  Paul J Kennedy; John F Cryan; Timothy G Dinan; Gerard Clarke
Journal:  World J Gastroenterol       Date:  2014-10-21       Impact factor: 5.742

Review 3.  Changing face of irritable bowel syndrome.

Authors:  Eamonn M M Quigley
Journal:  World J Gastroenterol       Date:  2006-01-07       Impact factor: 5.742

Review 4.  Gastrointestinal eosinophils in health, disease and functional disorders.

Authors:  Nicholas Powell; Marjorie M Walker; Nicholas J Talley
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2010-02-02       Impact factor: 46.802

Review 5.  Bugs on the brain; brain in the gut--seeking explanations for common gastrointestinal symptoms.

Authors:  E M M Quigley
Journal:  Ir J Med Sci       Date:  2012-11-22       Impact factor: 1.568

6.  Leveraging 16S rRNA Microbiome Sequencing Data to Identify Bacterial Signatures for Irritable Bowel Syndrome.

Authors:  Yuxia Liu; Wenhui Li; Hongxia Yang; Xiaoying Zhang; Wenxiu Wang; Sitong Jia; Beibei Xiang; Yi Wang; Lin Miao; Han Zhang; Lin Wang; Yujing Wang; Jixiang Song; Yingjie Sun; Lijuan Chai; Xiaoxuan Tian
Journal:  Front Cell Infect Microbiol       Date:  2021-06-11       Impact factor: 5.293

7.  In Vivo and In Vitro Antinociceptive Effect of Fagopyrum cymosum (Trev.) Meisn Extracts: A Possible Action by Recovering Intestinal Barrier Dysfunction.

Authors:  Lina Liu; Xueting Cai; Jing Yan; Yi Luo; Ming Shao; Yin Lu; Zhiguang Sun; Peng Cao
Journal:  Evid Based Complement Alternat Med       Date:  2012-12-17       Impact factor: 2.629

8.  Pimpinella anisum in the treatment of functional dyspepsia: A double-blind, randomized clinical trial.

Authors:  S Ashraffodin Ghoshegir; Mohammad Mazaheri; Alireza Ghannadi; Awat Feizi; Mahmoud Babaeian; Maryam Tanhaee; Mehrdad Karimi; Peyman Adibi
Journal:  J Res Med Sci       Date:  2015-01       Impact factor: 1.852

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.